Orthopaedic companies Stratec and Synthes to merge
This article was originally published in Clinica
Orthopaedics companies Synthes and Stratec are to merge, to become one of the world's leading trauma repair companies with turnover of around SwFr883 million ($600 million). The new holding company will be called Synthes-Stratec and will be based in Delaware, US. No financial terms were disclosed.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.